granisetron has been researched along with Cancer of Gastrointestinal Tract in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akashi, K; Ariyama, H; Baba, E; Esaki, T; Hirano, G; Inadomi, K; Ito, M; Kumagai, H; Kusaba, H; Makiyama, A; Makiyama, C; Mitsugi, K; Nio, K; Shibata, Y; Shirakawa, T; Takayoshi, K; Tamura, S; Yamanaka, T | 1 |
| Hashimoto, H; Murakami, M; Senba, S; Siraishi, T; Yamaguchi, I; Yamaguchi, K | 1 |
2 trial(s) available for granisetron and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Drug Therapy, Combination; Female; Gastrointestinal Neoplasms; Granisetron; Humans; Male; Middle Aged; Morpholines; Nausea; Prospective Studies; Serotonin Antagonists; Vomiting | 2018 |
Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Granisetron; Humans; Isoquinolines; Male; Middle Aged; Nausea; Palonosetron; Prospective Studies; Quinuclidines; Surveys and Questionnaires; Vomiting | 2014 |